Skip to main content

About your Search

20130121
20130129
STATION
KQEH (PBS) 5
LANGUAGE
Search Results 0 to 4 of about 5 (some duplicates have been removed)
PBS
Jan 26, 2013 4:00pm PST
own healthcare decisions to come talk about their resolve in the face of fierce opposition from the right. jessica gonzÁlez-rojas is executive director of the national latina institute for reproductive health. she is an adjunct professor of latino and latin american studies at the city university of new york and has taught courses on reproductive rights, gender, and sexuality. lynn paltrow is founder and executive director of national advocates for pregnant women. she has served as a senior staff attorney at the aclu's reproductive freedom project and recently published this study in the american journal of public health, "roe v. wade and the new jane crow." welcome to you both. >> thank you. >> thank you. >> before we get to what you're up against 40 years after roe versus wade, i want to ask you a question from your own experience, long experience in both cases of working with women. what does compulsory childbearing mean to a woman? what are the effects of knowing that you are not free to decide for yourselves whether to become a mother or not? >> well, we know that when abortio
PBS
Jan 28, 2013 6:30pm PST
generic medicine as a way to trim healthcare costs. one of the beneficiaries has been watson pharmaceuticals. ruben ramirez reports. >> reporter: watson pharmaceuticals has a new name and a new logo. the world's third-largest generic drug maker changed its name to actavis, a company watson bought last fall. c.e.o. paul bisaro says its no stranger to growth through acquisitions. >> in the short-term we'll be looking for add-on acquisitions whether it's in the branded space where we continue to be very aggressive in the areas of women's health and urology trying to find new therapies we can bring to market. i think a bigger transaction for us would probably await 2014, or 2015. >> reporter: with acquisitions come redundancies, actavis is cutting jobs and moving operations out of its original corona, california facility. >> most of the products that are manufactured in that facility will be moving to our florida facility or our elizabeth, n.j. facility, so there will be some additional increases in people in those facilities. we'll also be moving to some overseas locations. >> r
Search Results 0 to 4 of about 5 (some duplicates have been removed)